New Zealand Health Terminology Service (NZHTS) Implementation Guide
0.1.0 - ci-build
New Zealand Health Terminology Service (NZHTS) Implementation Guide
0.1.0 - ci-build
New Zealand Health Terminology Service (NZHTS) Implementation Guide, published by Health New Zealand | Te Whatu Ora. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/daniel-thomson/nzhts/ and changes regularly. See the Directory of published versions
| Official URL: https://nzhts.digital.health.nz/fhir/ValueSet/canshare-b-cell-lymphoid-cancer-type | Version: 0.1.0 | |||
| Active as of 2024-11-11 | Computable Name: canshare-b-cell-lymphoid-cancer-type | |||
| Other Identifiers: http://canshare.co.nz/fhir/NamingSystem/valuesets#canshare-b-cell-lymphoid-cancer-type | ||||
The type of B cell lymphoid haematologic cancer being assessed and treated.
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
Generated Narrative: ValueSet canshare-b-cell-lymphoid-cancer-type
version: 1; Last updated: 2024-11-05 17:12:38+1300; Language: en-x-sctlang-23162100-0210105
This value set includes codes based on the following rules:
http://snomed.info/sct where constraint = ^ 302721000210107 |New Zealand cancer B-cell lymphoid cancer type reference set| MINUS (92081000210108 |B-cell lymphoid proliferation| OR 392031000210109 |Aggressive B cell lymphoma| OR 351651000210106 |Indolent B cell lymphoma| OR 351671000210103 |Plasma cell disorder|)http://snomed.info/sct
| Code | Display |
| 351651000210106 | Other indolent B cell lymphoma |
| 392031000210109 | Other aggressive B cell lymphoma |
| 92081000210108 | Other B-cell lymphoid proliferation |
| 351671000210103 | Other plasma cell disorder |
Generated Narrative: ValueSet canshare-b-cell-lymphoid-cancer-type
version: 1; Last updated: 2024-11-05 17:12:38+1300; Language: en-x-sctlang-23162100-0210105
Expansion based on SNOMED CT 21000210109 edition 01-Oct 2024
This value set contains 19 concepts
| Code | System | Display - English (English, en) |
| 351651000210106 | http://snomed.info/sct | Other indolent B cell lymphoma |
| 392031000210109 | http://snomed.info/sct | Other aggressive B cell lymphoma |
| 351671000210103 | http://snomed.info/sct | Other plasma cell disorder |
| 17602002 | http://snomed.info/sct | Amyloidosis |
| 351681000210101 | http://snomed.info/sct | B lymphoblastic leukaemia lymphoma |
| 392081000210108 | http://snomed.info/sct | B-cell lymphoproliferative disorder |
| 118617000 | http://snomed.info/sct | Burkitt's lymphoma (clinical) |
| 207036003 | http://snomed.info/sct | Castleman disease |
| 351691000210104 | http://snomed.info/sct | Chronic lymphocytic leukemia and/or small lymphocytic lymphoma |
| 308121000 | http://snomed.info/sct | Follicular lymphoma |
| 118613001 | http://snomed.info/sct | Hairy cell leukaemia (clinical) |
| 118599009 | http://snomed.info/sct | Hodgkin's disease (clinical) |
| 307623001 | http://snomed.info/sct | Malignant lymphoma - lymphoplasmacytic |
| 443487006 | http://snomed.info/sct | Mantle cell lymphoma |
| 447100004 | http://snomed.info/sct | Marginal zone lymphoma |
| 717780007 | http://snomed.info/sct | Monoclonal B-cell lymphocytosis |
| 109989006 | http://snomed.info/sct | Multiple myeloma |
| 307649006 | http://snomed.info/sct | Primary central nervous system lymphoma |
| 444910004 | http://snomed.info/sct | Primary mediastinal (thymic) large B-cell lymphoma |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |